Presentation is loading. Please wait.

Presentation is loading. Please wait.

Does the Choice of Chemotherapeutic Agent, Mitomycin C vs Oxaliplatin, Matter in Cytoreductive Surgery and Hyperthemic Intraperitoneal Chemotherapy? 

Similar presentations


Presentation on theme: "Does the Choice of Chemotherapeutic Agent, Mitomycin C vs Oxaliplatin, Matter in Cytoreductive Surgery and Hyperthemic Intraperitoneal Chemotherapy? "— Presentation transcript:

1 Does the Choice of Chemotherapeutic Agent, Mitomycin C vs Oxaliplatin, Matter in Cytoreductive Surgery and Hyperthemic Intraperitoneal Chemotherapy?  Irada Ibrahim-Zada, MD, PhD, Camille Stewart, Rodrigo Asturias Luna, Alyssa Blood, Csaba Gajdos, MD, FACS, Barish Edil, Nathan Pearlman, MD, Ana Gleisner, MD, PhD, Martin D. McCarter, MD, FACS  Journal of the American College of Surgeons  Volume 225, Issue 4, Pages S190-S191 (October 2017) DOI: /j.jamcollsurg Copyright © Terms and Conditions

2 Journal of the American College of Surgeons  , S190-S191DOI: ( /j.jamcollsurg ) Copyright © Terms and Conditions


Download ppt "Does the Choice of Chemotherapeutic Agent, Mitomycin C vs Oxaliplatin, Matter in Cytoreductive Surgery and Hyperthemic Intraperitoneal Chemotherapy? "

Similar presentations


Ads by Google